• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用磁共振成像和动态胃肠道系统评估食物依赖的速释福沙那韦片剂的崩解情况。

Food-dependent disintegration of immediate release fosamprenavir tablets: in vitro evaluation using magnetic resonance imaging and a dynamic gastrointestinal system.

机构信息

Laboratory for Pharmacotechnology and Biopharmacy, Katholieke Universiteit Leuven, Leuven, Belgium.

出版信息

Eur J Pharm Biopharm. 2011 Feb;77(2):313-9. doi: 10.1016/j.ejpb.2010.10.009. Epub 2010 Nov 3.

DOI:10.1016/j.ejpb.2010.10.009
PMID:21055466
Abstract

In the present study, we demonstrated the value of two advanced tools, the TNO gastric and small Intestinal Model (TIM-1) and magnetic resonance imaging (MRI), for the in vitro evaluation of food-dependent disintegration of immediate release fosamprenavir tablets. Upon introduction of a tablet with the nutritional drink Scandishake Mix® in the stomach compartment of TIM-1, simulating the fed state, disintegration and fosamprenavir dissolution were significantly postponed compared to the fasted state (lag time 80 ± 23 min). This resulted in a lag in the appearance of bioaccessible fosamprenavir (<5% during the first 2h), even though the nutritional state did not significantly alter the cumulative bioaccessibility after 5h. These results were in agreement with the previously observed postprandial delay in gastric fosamprenavir tablet disintegration and subsequent amprenavir absorption in healthy volunteers. Therefore, TIM-1 can be used in tablet development to identify food-induced disintegration issues causing unexpected clinical behavior. From a mechanistic perspective, we applied MRI to illustrate impaired water ingress in fosamprenavir tablets immersed in the nutritional drink compared to simulated gastric fluid. This effect may be attributed to both competition between nutritional components and the tablet for the available water (indicated by reduced rotational and translational diffusion) as well as the possible formation of a food-dependent precipitation layer on the HPMC-coated tablet.

摘要

在本研究中,我们展示了两种先进工具的价值,即 TNO 胃和小肠模型(TIM-1)和磁共振成像(MRI),用于体外评估食物依赖性即刻释放福沙那韦片剂的崩解。在 TIM-1 的胃腔部分引入含有营养饮料 Scandishake Mix®的片剂,模拟进食状态,与空腹状态相比,崩解和福沙那韦溶解明显延迟(滞后时间 80±23 分钟)。这导致生物可利用的福沙那韦出现时间延迟(在最初 2 小时内<5%),尽管营养状态在 5 小时后并没有显著改变累积生物可利用度。这些结果与之前在健康志愿者中观察到的餐后胃福沙那韦片剂崩解延迟以及随后的氨普那韦吸收相一致。因此,TIM-1 可用于片剂开发,以识别导致意外临床行为的食物诱导崩解问题。从机制角度来看,我们应用 MRI 来阐明在营养饮料中浸泡的福沙那韦片剂中水分进入的受损情况,与模拟胃液相比。这种效应可能归因于营养成分和片剂对可用水的竞争(由旋转和平移扩散减少表明)以及 HPMC 涂层片剂上可能形成的食物依赖性沉淀层。

相似文献

1
Food-dependent disintegration of immediate release fosamprenavir tablets: in vitro evaluation using magnetic resonance imaging and a dynamic gastrointestinal system.应用磁共振成像和动态胃肠道系统评估食物依赖的速释福沙那韦片剂的崩解情况。
Eur J Pharm Biopharm. 2011 Feb;77(2):313-9. doi: 10.1016/j.ejpb.2010.10.009. Epub 2010 Nov 3.
2
Parallel monitoring of plasma and intraluminal drug concentrations in man after oral administration of fosamprenavir in the fasted and fed state.在空腹和进食状态下口服福沙普那韦后,对人体血浆和管腔内药物浓度进行平行监测。
Pharm Res. 2007 Oct;24(10):1862-9. doi: 10.1007/s11095-007-9307-3. Epub 2007 Apr 19.
3
Pharmacokinetics of concurrent administration of fosamprenavir and atazanavir without ritonavir in human immunodeficiency virus-negative subjects.在人类免疫缺陷病毒阴性受试者中同时给予福沙普那韦和阿扎那韦(不联用利托那韦)的药代动力学
Pharmacotherapy. 2009 Aug;29(8):937-42. doi: 10.1592/phco.29.8.937.
4
Food effects on tablet disintegration.食物对片剂崩解的影响。
Eur J Pharm Sci. 2004 Jun;22(2-3):165-72. doi: 10.1016/j.ejps.2004.03.004.
5
In vitro behavior of a phosphate ester prodrug of amprenavir in human intestinal fluids and in the Caco-2 system: illustration of intraluminal supersaturation.安普那韦磷酸酯前药在人肠液和Caco-2系统中的体外行为:肠腔内过饱和现象说明
Int J Pharm. 2007 May 24;336(2):302-9. doi: 10.1016/j.ijpharm.2006.12.011. Epub 2006 Dec 14.
6
Fosamprenavir/ritonavir plus tenofovir does not affect amprenavir pharmacokinetics: no effect of tenofovir.福沙那韦/利托那韦加替诺福韦不影响安普那韦的药代动力学:替诺福韦无影响。
AIDS. 2007 Jun 19;21(10):1368-70. doi: 10.1097/QAD.0b013e32810c8ce2.
7
Fosamprenavir plus ritonavir increases plasma ketoconazole and ritonavir exposure, while amprenavir exposure remains unchanged.福沙那韦联合利托那韦可增加血浆酮康唑和利托那韦的暴露量,而安普那韦的暴露量保持不变。
Antimicrob Agents Chemother. 2007 Aug;51(8):2982-4. doi: 10.1128/AAC.00008-07. Epub 2007 May 21.
8
Ritonavir increases plasma amprenavir (APV) exposure to a similar extent when coadministered with either fosamprenavir or APV.与福沙那韦或安普那韦合用时,利托那韦可使血浆安普那韦(APV)暴露量增加至相似程度。
Antimicrob Agents Chemother. 2006 Apr;50(4):1578-80. doi: 10.1128/AAC.50.4.1578-1580.2006.
9
Long-term (120-Week) antiviral efficacy and tolerability of fosamprenavir/ritonavir once daily in therapy-naive patients with HIV-1 infection: an uncontrolled, open-label, single-arm follow-on study.福沙普瑞那韦/利托那韦每日一次用于初治HIV-1感染患者的长期(120周)抗病毒疗效及耐受性:一项非对照、开放标签、单臂随访研究
Clin Ther. 2006 May;28(5):745-54. doi: 10.1016/j.clinthera.2006.05.011.
10
Fosamprenavir: drug development for adherence.福沙普那韦:为提高依从性而进行的药物研发。
Ann Pharmacother. 2006 Jul-Aug;40(7-8):1301-10. doi: 10.1345/aph.1G034. Epub 2006 Jun 6.

引用本文的文献

1
In Vitro and In Vivo Evaluation of Magnetic Floating Dosage Form by Alternating Current Biosusceptometry.基于交流电生物磁测量法的磁悬浮剂型的体外和体内评价
Pharmaceutics. 2024 Mar 2;16(3):351. doi: 10.3390/pharmaceutics16030351.
2
Use of Magnetic Resonance Imaging for Visualization of Oral Dosage Forms in the Human Stomach: A Scoping Review.磁共振成像在人体胃部可视化口腔剂型中的应用:范围综述。
Mol Pharm. 2024 Apr 1;21(4):1553-1562. doi: 10.1021/acs.molpharmaceut.3c01123. Epub 2024 Mar 5.
3
Effect of Food and a Proton-Pump Inhibitor on the Absorption of Encorafenib: An -- Approach.
食物和质子泵抑制剂对恩考芬尼吸收的影响:一种 -- 方法。
Mol Pharm. 2023 May 1;20(5):2589-2599. doi: 10.1021/acs.molpharmaceut.3c00016. Epub 2023 Apr 10.
4
Use of In Vitro Dynamic Colon Model (DCM) to Inform a Physiologically Based Biopharmaceutic Model (PBBM) to Predict the In Vivo Performance of a Modified-Release Formulation of Theophylline.使用体外动态结肠模型(DCM)为基于生理学的生物药剂学模型(PBBM)提供信息,以预测茶碱缓释制剂的体内性能。
Pharmaceutics. 2023 Mar 9;15(3):882. doi: 10.3390/pharmaceutics15030882.
5
Oil-Based Delivery Control Release System Targeted to the Later Part of the Gastrointestinal Tract-A Mechanistic Study.靶向胃肠道后半段的油基给药控释系统——一项机制研究
Pharmaceutics. 2022 Apr 20;14(5):896. doi: 10.3390/pharmaceutics14050896.
6
PET microplastics affect human gut microbiota communities during simulated gastrointestinal digestion, first evidence of plausible polymer biodegradation during human digestion.在模拟胃肠道消化过程中,PET微塑料会影响人体肠道微生物群落,这是人类消化过程中聚合物可能发生生物降解的首个证据。
Sci Rep. 2022 Jan 11;12(1):528. doi: 10.1038/s41598-021-04489-w.
7
Compatibility, Cytotoxicity, and Gastrointestinal Tenacity of Bacteriocin-Producing Bacteria Selected for a Consortium Probiotic Formulation to Be Used in Livestock Feed.用于牲畜饲料的协同益生菌配方中选择的产细菌素细菌的相容性、细胞毒性和胃肠道稳定性。
Probiotics Antimicrob Proteins. 2021 Feb;13(1):208-217. doi: 10.1007/s12602-020-09687-y.
8
Enteric Hard Capsules for Targeting the Small Intestine: Positive Correlation between In Vitro Disintegration and Dissolution Times.用于靶向小肠的肠溶硬胶囊:体外崩解时间与溶出时间的正相关
Pharmaceutics. 2020 Feb 3;12(2):123. doi: 10.3390/pharmaceutics12020123.
9
Identification of beagle food taking patterns and protocol for food effects evaluation on bioavailability.鉴定比格犬的摄食模式和用于评估生物利用度的食物效应方案。
Sci Rep. 2018 Aug 24;8(1):12765. doi: 10.1038/s41598-018-30937-1.
10
Evaluation and Comparison of Three Types of Spray Dried Coprocessed Excipient Avicel® for Direct Compression.三种喷雾干燥共处理辅料 Avicel® 直接压片的评价与比较。
Biomed Res Int. 2018 Apr 19;2018:2739428. doi: 10.1155/2018/2739428. eCollection 2018.